Overview
Jingru Liu practices practicing medicine in Fuzhou, China.
Their clinical expertise encompasses Acute Myeloid Leukemia (AML), Diffuse Large B-Cell Lymphoma (DLBCL), Leukemia, and B-Cell Lymphoma.
They are actively involved in clinical research, co-authoring 20 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jingru Liu
Is Jingru Liu a top-rated expert for Acute Myeloid Leukemia (AML)?
MediFind is an objective health platform that identifies experts based on real-world data. Jingru Liu is classified as an Experienced expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jingru Liu participate in research or clinical trials?
Yes. Jingru Liu has published 20 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Jingru Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Myeloid Leukemia (AML)
- B-Cell LymphomaLiu isExperienced. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- LeukemiaLiu isExperienced. Learn about Leukemia.
- Non-Hodgkin LymphomaLiu isExperienced. Learn about Non-Hodgkin Lymphoma.